Related Experiment Video
Updated: Jun 24, 2026

10:35
A Procedure to Study the Effect of Prolonged Food Restriction on Heroin Seeking in Abstinent Rats
Published on: November 11, 2013
Harm reduction policies in Argentina: a critical view
1University of Buenos Aires & CONICET, Buenos Aires, Argentina. epele@netverk.com.ar
Global Public Health
|March 14, 2009
Summary
This study broadens the definition of harm in drug policies beyond health issues to include social and economic impacts. It examines Argentina
Area of Science:
- Public Health
- Sociology
- Criminology
Background:
- Current drug harm reduction policies primarily focus on health consequences like viral infections.
- Criminalization of drug use and poverty exacerbate harms experienced by drug users.
- Argentina faces rising poverty, shifting drug use patterns, and changing drug quality and prices.
Purpose of the Study:
- To challenge and expand the narrow definition of harm in drug harm reduction.
- To analyze harm reduction policies in Argentina, considering broader social and economic factors.
- To explore the application of harm reduction in a context of criminalization and poverty.
Main Methods:
- Policy analysis of harm reduction initiatives in Argentina.
- Qualitative assessment of harms experienced by drug users in impoverished areas.
- Comparative analysis with individualistic, public health models from the Global North.
Main Results:
- Harm reduction policies in Argentina are adapting to address a wider spectrum of harms.
- There is a tension between globalized, individualistic health models and local, collective approaches.
- Socio-economic factors significantly influence the nature and extent of harm experienced by drug users.
Conclusions:
- A comprehensive understanding of harm in drug policy must include social, economic, and political dimensions.
- Harm reduction strategies need to be context-specific, acknowledging local realities of poverty and criminalization.
- Argentina's approach offers insights into adapting global health frameworks to diverse socio-economic contexts.
Related Concept Videos
Drug Control Governance: Regulatory Bodies and Their Impact
Drug control governance involves the oversight and regulation of pharmaceuticals to ensure their safety and efficacy while preventing illegal drug use and trafficking. Regulatory bodies, including the US Food and Drug Administration (FDA) and the European Union's European Medicines Agency (EMA), play a central role in this process. These agencies evaluate the safety and efficacy of drugs before they can be marketed. They fund clinical trials and assess the benefits and risks associated with a...
Drug Regulation
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
Phase I Reactions: Reductive Reactions
Phase I biotransformation reductive reactions are chemical processes that modify drugs by introducing or revealing polar functional groups via reduction. Enzymes called reductases catalyze these reactions, playing a pivotal role in drug metabolism by transforming lipophilic drugs into more polar, water-soluble metabolites for easy excretion. An essential type of reductive reaction is the carbonyl group reduction, where aldehydes and ketones are reduced to alcohols. An example is the...
Combined Effects of Drugs: Antagonism
The combined effects of drugs can result in various interactions, of which an important type is antagonism. Antagonism is a mechanism where one drug inhibits or counteracts the effects of another drug. Antagonism can occur through various means, including receptor binding, allosteric modulation, functional interaction, chemical reactions, and pharmacokinetic processes.
The most common type is receptor antagonism, where one drug acts as an antagonist to block the effects of another drug by...
The most common type is receptor antagonism, where one drug acts as an antagonist to block the effects of another drug by...
Retrovirus Life Cycles
Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the retrovirus to...
Drug Therapy
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications

